Search

Your search keyword '"Bax H.I."' showing total 22 results

Search Constraints

Start Over You searched for: Author "Bax H.I." Remove constraint Author: "Bax H.I."
22 results on '"Bax H.I."'

Search Results

1. External validation of the PAGE-B score for HCC risk prediction in people living with HIV/HBV coinfection

2. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

3. Real-world effectiveness and tolerability of switching to doravirine-based antiretroviral therapy in people with HIV: a nationwide, matched, prospective cohort study

4. A multicentre verification study of the QuantiFERON®-TB Gold Plus assay

5. The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy.

6. The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy

7. The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults

8. Treatment and Outcome of Culture-Confirmed Mycobacterium marinum Disease

9. The 2021 Dutch Working Party on Antibiotic Policy (SWAB) guidelines for empirical antibacterial therapy of sepsis in adults

12. Response to correspondence concerning: “Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients”

13. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study

14. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients

15. Mycobacterium chelonae, an ‘atypical’ cause of an LVAD driveline infection

16. Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV

17. High treatment uptake in human immunodeficiency virus/ hepatitis C virus-coinfected patients after unrestricted access to direct-acting antivirals in the Netherlands

18. Improving treatment outcome assessment in a mouse tuberculosis model

21. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

22. Human Immunodeficiency Virus Continuum of Care in 11 European Union Countries at the End of 2016 Overall and by Key Population: Have We Made Progress?

Catalog

Books, media, physical & digital resources